First Time Loading...

Resmed Inc
NYSE:RMD

Watchlist Manager
Resmed Inc Logo
Resmed Inc
NYSE:RMD
Watchlist
Price: 214.9 USD -0.05% Market Closed
Updated: May 2, 2024
Section:
 

Relative Value

The Relative Value of one RMD stock under the Base Case scenario is 210.31 USD. Compared to the current market price of 214.9 USD, Resmed Inc is Overvalued by 2%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RMD Relative Value
Base Case
210.31 USD
Overvaluation 2%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

6.9
P/S
P/S
Price to Sales
6.9
vs History
77
vs Industry
20
Median 3Y
8.7
Median 5Y
8.2
Industry
2.4
Forward
6.7
More Details
32.9
P/E
P/E
Price to Earnings
32.9
vs History
80
vs Industry
17
Median 3Y
40.2
Median 5Y
41.3
Industry
23.2
Forward
28.7
More Details
26.3
P/OCF
P/OCF
Price to OCF
26.3
vs History
85
vs Industry
15
Median 3Y
58.1
Median 5Y
38.4
Industry
15.5
More Details
69.8
P/FCFE
P/FCFE
Price to FCFE
69.8
vs History
42
vs Industry
8
Median 3Y
105.8
Median 5Y
55.8
Industry
23.5
More Details
6.8
P/B
P/B
Price to Book Value
6.8
vs History
84
vs Industry
11
Median 3Y
9
Median 5Y
9.4
Industry
2.2
More Details
7.1
EV/S
EV/S
Enterprise Value to Sales
7.1
vs History
77
vs Industry
18
Median 3Y
8.9
Median 5Y
8.4
Industry
2.5
Forward
6.9
More Details
12.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
12.6
vs History
76
vs Industry
17
Median 3Y
15.7
Median 5Y
14.9
Industry
5.2
More Details
22
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
22
vs History
80
vs Industry
15
Median 3Y
27.2
Median 5Y
27.1
Industry
12.5
Forward
20.9
More Details
25.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
25.1
vs History
84
vs Industry
19
Median 3Y
31.8
Median 5Y
32
Industry
17.2
Forward
23
More Details
27
EV/OCF
EV/OCF
Enterprise Value to OCF
27
vs History
87
vs Industry
16
Median 3Y
59.1
Median 5Y
39.9
Industry
15.1
More Details
30.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
30.2
vs History
88
vs Industry
18
Median 3Y
82.1
Median 5Y
48
Industry
19.7
More Details
5.1
EV/IC
EV/IC
Enterprise Value to IC
5.1
vs History
76
vs Industry
17
Median 3Y
6.5
Median 5Y
5.8
Industry
2
More Details

Multiples Across Competitors

RMD Competitors Multiples
Resmed Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Resmed Inc
NYSE:RMD
31.6B USD 6.9 32.9 22 25.1
US
Abbott Laboratories
NYSE:ABT
182.6B USD 4.5 32.4 19.1 28.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
132.5B USD 18.1 66.7 54.7 68.5
US
Stryker Corp
NYSE:SYK
123.5B USD 5.9 36.7 23.9 29.4
IE
Medtronic PLC
NYSE:MDT
107.2B USD 3.3 25.5 13.6 19.3
US
Boston Scientific Corp
NYSE:BSX
104.5B USD 7.1 59.2 30.2 44.6
US
Becton Dickinson and Co
NYSE:BDX
67.6B USD 3.5 55.5 18.6 39.3
DE
Siemens Healthineers AG
XETRA:SHL
57.2B EUR 2.6 37.7 18.2 30.6
US
Edwards Lifesciences Corp
NYSE:EW
51.1B USD 8.3 36.1 26.2 28.4
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
368.4B CNY 10.7 32.5 28.3 28.3
US
Dexcom Inc
NASDAQ:DXCM
50B USD 13.1 78.2 58.4 76.1

See Also

Summary
RMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
RMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RMD stock valuation using valuation multiples.
Wall Street Estimates
RMD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.